(Q34341575)

English

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

based on heuristic

inferred from title

0 references

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Robert A Kuschner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Kevin L Russell

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mary Abuja

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Kristen M Bauer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Dennis J Faix

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Howard Hait

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jennifer Henrick

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Michael Jacobs

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alan Liss

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Julia A Lynch

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Qi Liu

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Arthur G Lyons

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mohammad Malik

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jeremiah Stubbs

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Wellington Sun

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Doug Tang

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Andrew C Towle

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Douglas S Walsh

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Deborah Wilkerson

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Adenovirus Vaccine Efficacy Trial Consortium

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

0 references

publication date

25 April 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2963-2971

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23623865%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Emergence of adenovirus type 14 in US military recruits--a new challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Adenovirus vaccines in the U.S. military

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Respiratory disease and the adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Abrupt emergence of diverse species B adenoviruses at US military recruit training centers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Sample size and power for prospective analysis of relative risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Adenoviral infection in military recruits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Spread of enteric live adenovirus type 4 vaccine in married couples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Communicability of enteric live adenovirus type 4 vaccine in families.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.035

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34341575&oldid=1406393586"